Fig. 3: LV-si-RBP1 suppressed tumor growth in vivo.

a Representative graph showing tumor growth 32 days after subcutaneously implanted OSCC cells. b, c Calculated tumor volume and weight in LV-si-RBP1 and LV-control groups. d, e Expression of RBP1 as measured by qRT-PCR and western blot in LV-si-RBP1 and LV-control groups. f RBP1 expression was measured by immunohistochemistry staining in LV-si-RBP1 and LV-control groups. Scale bar: 100 μm; *P < 0.05, **P < 0.01.